Swedbank AB raised its position in shares of Solventum Co. (NYSE:SOLV - Free Report) by 20.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 107,197 shares of the company's stock after buying an additional 18,108 shares during the period. Swedbank AB owned about 0.06% of Solventum worth $7,474,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Deseret Mutual Benefit Administrators purchased a new stake in shares of Solventum in the 2nd quarter worth about $25,000. Hollencrest Capital Management purchased a new position in shares of Solventum during the 2nd quarter worth approximately $25,000. Partnership Wealth Management LLC bought a new position in shares of Solventum in the 2nd quarter worth approximately $26,000. Richard W. Paul & Associates LLC bought a new stake in shares of Solventum during the second quarter valued at approximately $26,000. Finally, Family Firm Inc. purchased a new stake in Solventum in the second quarter worth $26,000.
Analyst Ratings Changes
A number of analysts have recently commented on the stock. Wolfe Research initiated coverage on shares of Solventum in a report on Thursday, September 26th. They set a "peer perform" rating on the stock. BTIG Research started coverage on shares of Solventum in a research note on Thursday, September 5th. They set a "neutral" rating on the stock. Piper Sandler raised their target price on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a research note on Friday, November 8th. Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research report on Monday, November 11th. Finally, Stifel Nicolaus initiated coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a "buy" rating and a $82.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $68.00.
View Our Latest Stock Analysis on SOLV
Solventum Stock Performance
Shares of SOLV stock traded up $0.83 during mid-day trading on Wednesday, hitting $72.32. The stock had a trading volume of 235,360 shares, compared to its average volume of 1,692,800. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm's 50-day moving average is $70.51 and its two-hundred day moving average is $62.40. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05.
Solventum Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
